Skip to main content

Bausch Health Companies Inc(BHC-T)
TSX

Today's Change
Real-Time Last Update
Day Low9.58
Day High9.85
Open:9.75
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc down on Thursday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc up on Tuesday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc up on Monday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc down on Friday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc down on Thursday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc down on Wednesday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc up on Tuesday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc down on Monday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc down on Friday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc down on Thursday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc up on Wednesday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc up on Tuesday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc up on Monday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc down on Friday (BHC)
AI-generated - The Globe and Mail
Closing Bell: Bausch Health Companies Inc down on Thursday (BHC)

Profile

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.